Connection

Co-Authors

This is a "connection" page, showing publications co-authored by KEPING XIE and SUYUN HUANG.
Connection Strength

4.132
  1. Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev. 2006 Jun; 17(3):147-56.
    View in: PubMed
    Score: 0.273
  2. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine Growth Factor Rev. 2004 Oct; 15(5):297-324.
    View in: PubMed
    Score: 0.248
  3. Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency. Free Radic Biol Med. 2003 Apr 15; 34(8):969-86.
    View in: PubMed
    Score: 0.224
  4. Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis. 2003; 20(1):31-43.
    View in: PubMed
    Score: 0.220
  5. Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression. J Biol Chem. 2015 Jul 24; 290(30):18662-70.
    View in: PubMed
    Score: 0.130
  6. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness. Clin Cancer Res. 2015 Feb 15; 21(4):844-53.
    View in: PubMed
    Score: 0.126
  7. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and ?-catenin signaling in pancreatic ductal adenocarcinoma cells. Gastroenterology. 2014 Aug; 147(2):485-97.e18.
    View in: PubMed
    Score: 0.121
  8. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res. 2014 May 15; 20(10):2595-606.
    View in: PubMed
    Score: 0.119
  9. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer. Cancer Res. 2013 Jul 01; 73(13):3987-96.
    View in: PubMed
    Score: 0.112
  10. The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin Cancer Res. 2013 Jan 01; 19(1):62-72.
    View in: PubMed
    Score: 0.109
  11. Dysregulated Kr?ppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology. 2012 Sep; 143(3):799-810.e2.
    View in: PubMed
    Score: 0.105
  12. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res. 2012 Feb 01; 72(3):655-65.
    View in: PubMed
    Score: 0.102
  13. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology. 2012 Mar; 142(3):531-42.
    View in: PubMed
    Score: 0.102
  14. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer Res. 2011 Aug 01; 71(15):5182-93.
    View in: PubMed
    Score: 0.099
  15. Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res. 2011 Jul 15; 71(14):4932-43.
    View in: PubMed
    Score: 0.098
  16. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes. Cancer Res. 2010 Apr 01; 70(7):2951-61.
    View in: PubMed
    Score: 0.091
  17. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer Res. 2010 Feb 01; 70(3):1111-9.
    View in: PubMed
    Score: 0.089
  18. Modeling liver metastasis using a tumor cell line derived from an enhanced green fluorescent protein transgenic mouse. Clin Exp Metastasis. 2010; 27(1):11-8.
    View in: PubMed
    Score: 0.088
  19. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res. 2009 Apr 15; 69(8):3501-9.
    View in: PubMed
    Score: 0.085
  20. Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer Res. 2008 Dec 01; 68(23):9634-42.
    View in: PubMed
    Score: 0.083
  21. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res. 2008 Nov 01; 68(21):8733-42.
    View in: PubMed
    Score: 0.082
  22. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res. 2006 Apr 01; 66(7):3593-602.
    View in: PubMed
    Score: 0.069
  23. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res. 2006 Mar 15; 66(6):3188-96.
    View in: PubMed
    Score: 0.069
  24. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis. 2006 Jan; 27(1):23-31.
    View in: PubMed
    Score: 0.067
  25. Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer. Clin Cancer Res. 2005 Aug 15; 11(16):5778-83.
    View in: PubMed
    Score: 0.066
  26. Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci U S A. 2005 Jun 14; 102(24):8758-63.
    View in: PubMed
    Score: 0.065
  27. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res. 2005 Jun 01; 65(11):4809-16.
    View in: PubMed
    Score: 0.065
  28. Drastic down-regulation of Kr?ppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005 Apr 01; 65(7):2746-54.
    View in: PubMed
    Score: 0.064
  29. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res. 2005 Feb 15; 11(4):1386-93.
    View in: PubMed
    Score: 0.064
  30. Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer. Gastric Cancer. 2005; 8(1):18-28.
    View in: PubMed
    Score: 0.063
  31. Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin Exp Metastasis. 2005; 22(3):205-13.
    View in: PubMed
    Score: 0.063
  32. A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clin Exp Metastasis. 2004; 21(8):755-64.
    View in: PubMed
    Score: 0.059
  33. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res. 2003 Dec 15; 9(17):6371-80.
    View in: PubMed
    Score: 0.059
  34. Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res. 2003 Jul 15; 63(14):3855-9.
    View in: PubMed
    Score: 0.057
  35. A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis. Oncogene. 2003 Mar 27; 22(12):1771-82.
    View in: PubMed
    Score: 0.056
  36. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 2003 Jan 23; 22(3):319-29.
    View in: PubMed
    Score: 0.055
  37. Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. J Interferon Cytokine Res. 1999 Dec; 19(12):1363-71.
    View in: PubMed
    Score: 0.044
  38. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res. 1999 Nov; 5(11):3711-21.
    View in: PubMed
    Score: 0.044
  39. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res. 1999 May 01; 59(9):2072-5.
    View in: PubMed
    Score: 0.043
  40. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2283-94.
    View in: PubMed
    Score: 0.039
  41. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2. Oncogene. 1997 Aug 14; 15(7):771-9.
    View in: PubMed
    Score: 0.038
  42. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. J Natl Cancer Inst. 1997 Mar 19; 89(6):421-7.
    View in: PubMed
    Score: 0.037
  43. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res. 1996 Dec; 2(12):1969-79.
    View in: PubMed
    Score: 0.036
  44. Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis. Cancer Immunol Immunother. 1996 Oct; 43(2):109-15.
    View in: PubMed
    Score: 0.036
  45. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res. 1995 Jul 15; 55(14):3123-31.
    View in: PubMed
    Score: 0.033
  46. Suppression of tumor growth and metastasis of murine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secrete the JE/MCP-1 cytokine. J Interferon Cytokine Res. 1995 Jul; 15(7):655-65.
    View in: PubMed
    Score: 0.033
  47. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med. 1995 Apr 01; 181(4):1333-43.
    View in: PubMed
    Score: 0.032
  48. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol Immunother. 1994 Oct; 39(4):231-8.
    View in: PubMed
    Score: 0.031
  49. FoxM1 promotes ?-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011 Oct 18; 20(4):427-42.
    View in: PubMed
    Score: 0.025
  50. Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res. 1998 Jul 01; 58(13):2733-6.
    View in: PubMed
    Score: 0.010
  51. A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res. 1996 Jan 15; 56(2):254-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.